Formulation for pain management
OwnerBrenton Harold Zettlinventor
Life of this patent
Estimating the term…
Abstract
A method of pain management is described, for use by individuals experiencing pain, comprising administration of a formulation comprising a plurality of cannabinoids. Primary cannabinoids are present in the formulation in amounts according to a weight ratio of THC:CBC:CBD ranging from 5:5:5 to 5:1:5. Methods of using the formulation, doses and dosage forms are described, including a formulation pairing in which a first formulation comprising CBC:CBD at 1:5 to 5:5 is utilized at certain times of day when psychoactive effects of THC are not desired, and a second formulation comprising THC:CBC:CBD is used at other times of day, typically evening or bedtime.
Claims6
A formulation pairing for use in a method of pain management by a subject in need thereof, said formulation pairing comprising a first formulation and a second formulation for use at different times of a multi-dose daily regimen;
- wherein the first formulation comprises cannabichromene (CBC), and cannabidiol (CBD) as primary cannabinoids, and an excipient;
- wherein the primary cannabinoids in the first formulation comprise or consist of, on a weight % basis:
- 17%-54% CBC;
- and 46%-83% CBD;
- and
- wherein the second formulation comprises tetrahydrocannabinol (THC), cannabichromene (CBC), and cannabidiol (CBD) as primary cannabinoids, and an excipient;
- wherein the primary cannabinoids in the second formulation comprise or consist of, on a weight % basis:
- 30%-45% THC;
- 9%-35% CBC;
- and 30%-45% CBD.
Dependencies are inferred from the claim text.